There's no money for pharmaceutical companies in telling people to stop eating process junk.

On this week's podcast, I had an amazing discussion with my buddy Mike Fave, who's been on the

podcast before. This is his second appearance. We talked about lipids, cholesterol, cardiovascular disease risk in the setting of

insulin sensitivity, context for all of this, and whether you should be taking a drug to lower your

cholesterol.

Pempedoic acid, statins, a zethemibe, PCS-K9 inhibitors,

we break it all down in this technical podcast.

In some ways, this podcast is a follow-up to something I recently did with Derek for more plates, more dates.

He had me on his podcast after I reached out to him, after seeing a clip of him and Peter Otea talking

about cardiovascular disease risk in the setting of different levels of

LDLs. So I went on Derek's podcast to help him understand context regarding

familial hyper cholesterol lemia and why medallion randomizations may not be the

end all and be all when it comes to

lipid levels and cardiovascular disease risk. So I'm going to send this

podcast to Derek and show him some of these things which add context,

everything we're talking about in that and we go into much more detail in this

podcast about all the drugs, risk benefit, all cause mortality, etc. So if you have

questions about your cholesterol, maybe it's gone up when you decrease seed oils and increase saturated fats which automatically come with an animal-based diet butter, gee, tallow, steaks.

Then this podcast is for you. It's technical, but bear with us. You'll learn a lot and I'm going to do my best to put in all the references in the video and in the show notes. So hopefully this video is very valuable for you and if you have more questions about lipids, cardiovascular disease risk, or anything you'd like to see me

discuss in future podcasts, please put it in the comments.

On to the podcast with Mike Faith.

All right, Mike, Fave, thanks for coming back on the podcast, man.

...